AGNICO EAGLE ANNOUNCES ADDITIONAL INVESTMENT IN OSISKO METALS INCORPORATED

https://mma.prnewswire.com/media/2847274/Agnico_Eagle_Mines_Limited_AGNICO_EAGLE_ANNOUNCES_ADDITIONAL_INV.jpg Stock Symbol: AEM (NYSE and TSX) Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) (“Agnico Eagle”) announced today that it has acquired 26,000,000 common shares (the “Common Shares”) of Osisko Metals Incorporated (“Osisko”) pursuant to a non-brokered private placement at a price of C$0.48 per Common Share for total consideration of C$12,480,000 (the “Private […]

ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR

(NYSE:ITGR), NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Integer Holdings Corporation (NYSE: ITGR) between July 25, 2024 and October 22, 2025, both dates inclusive (the “Class Period”). A class action lawsuit

ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR

ROSEN, NATIONALLY RECOGNIZED INVESTOR COUNSEL, Encourages Integer Holdings Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ITGR GlobeNewswire December 17, 2025 NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common

Jiaying Pharmaceutical: A New Pathway for the Industrialization of Century-Old Hakka Medicine

Recently,Meizhou in Guangdong, known as the “World Capital of the Hakka”, welcomed a globally watched event, the Seventh World Hakka Entrepreneurs Convention. At this gathering that drew the attention of Hakka entrepreneurs worldwide, Guangdong Jiaying Pharmaceutical Co., Ltd. made a brilliant appearance with its star products, including Double-ingredient Throat Wind Relief Powder, Solid Essence Ginseng

Churchill Capital Corp XI Announces the Pricing of Upsized $360 Million Initial Public Offering

Churchill Capital Corp XI (the “Company”) announced the pricing of its upsized initial public offering of 36,000,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market (“Nasdaq”) under the symbol “CCXIU” commencing today. Each unit consists of one Class A ordinary share of the Company and one-tenth of one

HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors

(NASDAQ:HCM),(LSE – AIM:HCM),(HKSE:0013), — First-in-human trial of candidate from the next-generation ATTC platform — — Simultaneous China and global clinical development strategy to expedite development process — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED“) (Nasdaq/AIM:​HCM; HKEX:​13) today announces the initiation of its global Phase

HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors

HUTCHMED Initiates Global Clinical Development of ATTC Candidate HMPL-A251 in Patients with Solid Tumors GlobeNewswire December 17, 2025 — First-in-human trial of candidate from the next-generation ATTC platform — — Simultaneous China and global clinical development strategy to expedite development process — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Dec. 17, 2025 (GLOBE NEWSWIRE)

Silver Viper Minerals Secures Agreement With IMPAQ Capital Inc.

Vancouver, BC / YOLOWIRE / December 16, 2025 / Silver Viper Minerals Corp. (TSXV: VIPR; OTCQB: VIPRF) (the "Company") (the "Company") is pleased to announce that it has engaged IMPAQ Capital Inc. ("IMPAQ"), an independent service provider, to deliver investor relations services. Based in Montréal, Québec, IMPAQ specializes in tailored outreach programs that connect companies

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

(NASDAQ:TLX), SAN FRANCISCO, Dec. 16, 2025 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd. (NASDAQ: TLX) that the deadline to move the Court for appointment as lead plaintiff in the pending securities class action lawsuit is January 9, 2026. The lawsuit follows a

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party Manufacturing Deficiencies (Form 483) GlobeNewswire December 16, 2025 SAN FRANCISCO, Dec. 16, 2025 (GLOBE NEWSWIRE)

Scroll to Top